The expression of tumor-derived cytokine MIF and its receptor CXCR4 were significantly associated with poor survivals of patients with ESCC; and the MIF and CXCR4 expression levels in tumor cells were independent predictive factors of survivals in patients with ESCC, as were the MIF expression level in TILs. This evidence concerns the gene MIF and neoplasm.